sb 203580 has been researched along with Coronary Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, WQ; Li, DH; Li, L; Qu, N; Wen, WM | 1 |
| Chvatchko, Y; Corbaz, A; Dimmeler, S; Haendeler, J; Reinhold, J; Rochwalsky, U; Rössig, L; Seeger, FH; Urbich, C; Walter, DH; Zeiher, AM | 1 |
2 other study(ies) available for sb 203580 and Coronary Disease
| Article | Year |
|---|---|
Coronary microembolization induced myocardial contractile dysfunction and tumor necrosis factor-α mRNA expression partly inhibited by SB203580 through a p38 mitogen-activated protein kinase pathway.
Topics: Animals; Blotting, Western; Coronary Disease; Echocardiography; Embolism; Imidazoles; Immunohistochemistry; Microcirculation; Myocardial Contraction; Myocardium; p38 Mitogen-Activated Protein Kinases; Pyridines; Random Allocation; Rats; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2011 |
p38 mitogen-activated protein kinase downregulates endothelial progenitor cells.
Topics: Activating Transcription Factor 2; Adult; Aged; Amino Acid Sequence; Animals; Apoptosis; Cell Count; Cell Differentiation; Cell Division; Cells, Cultured; Comorbidity; Coronary Disease; Cyclic AMP Response Element-Binding Protein; Female; Glucose; Hindlimb; Humans; Imidazoles; Ischemia; Isoquinolines; Male; Mice; Mice, Nude; Middle Aged; Molecular Sequence Data; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Processing, Post-Translational; Pyridines; Ribosomal Protein S6 Kinases, 90-kDa; Risk Factors; Signal Transduction; Stem Cell Transplantation; Stem Cells; Sulfonamides; Transcription Factors; Transplantation, Heterologous; Tumor Necrosis Factor-alpha | 2005 |